Comerica Bank’s Iovance Biotherapeutics IOVA Stock Holding History

Comerica Bank’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$19.7K	Hold	7,230	–	–	﹤0.01%	3093
2025 Q3	$15.7K	Hold	7,230	–	–	﹤0.01%	3151
2025 Q2	$12.4K	Buy	7,230 +563	+8%	+$1.4K	﹤0.01%	3160
2025 Q1	$22.2K	Sell	6,667 -256	-4%	-$1.32K	﹤0.01%	3001
2024 Q4	$51.2K	Buy	6,923 +227	+3%	+$2.1K	﹤0.01%	2800
2024 Q3	$62.9K	Buy	6,696 +282	+4%	+$2.67K	﹤0.01%	2720
2024 Q2	$51.4K	Buy	6,414 +12	+0.2%	+$129	﹤0.01%	2744
2024 Q1	$94.9K	Buy	6,402 +172	+3%	+$2K	﹤0.01%	2570
2023 Q4	$50.6K	Sell	6,230 -417	-6%	-$2.18K	﹤0.01%	2720
2023 Q3	$30.2K	Buy	+6,647	New	+$43.4K	﹤0.01%	2864
2021 Q1	–	Sell	-4,590	Closed	-$218K	–	2350
2020 Q4	$218K	Buy	+4,590	New	+$182K	﹤0.01%	2230

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Comerica Bank's IOVA Position: Q4 2025 in Review

Comerica Bank held its Iovance Biotherapeutics (IOVA) position steady in Q4 2025 at 7,230 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3093.

Comerica Bank first reported a position in IOVA in Q4 2020 and has held it in 11 quarters since. The position peaked at $218K in Q4 2020. 263 funds tracked by Wall St. Rank hold IOVA as of Q4 2025.

Comerica Bank held 7,230 shares of Iovance Biotherapeutics worth $19.7K as of Q4 2025.
Comerica Bank left its Iovance Biotherapeutics share count unchanged in Q4 2025.
Iovance Biotherapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3093 holding.
Comerica Bank first reported a position in Iovance Biotherapeutics in Q4 2020 and has held it in 11 quarters since.
Comerica Bank's Iovance Biotherapeutics position peaked at $218K in Q4 2020.
263 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.